Baicalin exhibits great potential in the field of cancer management by triggering apoptosis, suppressing miRs, influencing the expression of proteins regulating cell death, enhancing the functions of Bax and p53, and increasing the levels of cyclin-dependent kinase inhibitors [189]. The gene discussed is BAX; the disease is cancer.